Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes.

ABSTRACT: Although recent work has described the microbiome in solid tumors, microbial content in hematological malignancies is not well-characterized. Here we analyze existing deep DNA sequence data from the blood and bone marrow of 1870 patients with myeloid malignancies, along with healthy controls, for bacterial, fungal, and viral content. After strict quality filtering, we find evidence for dysbiosis in disease cases, and distinct microbial signatures among disease subtypes. We also find that microbial content is associated with host gene mutations and with myeloblast cell percentages. In patients with low-risk myelodysplastic syndrome, we provide evidence that Epstein-Barr virus status refines risk stratification into more precise categories than the current standard. Motivated by these observ

SUBMITTER: Woerner J 

PROVIDER: S-EPMC8873459 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature